Reporter Aug 16 2013

Creativity helps spur VUMC operational savings

As Vanderbilt University Medical Center navigates large-scale operational change through Evolve to Excel (E2E) a number of creative and substantive cost savings initiatives have already been identified. The Medical Center’s first priority remains to achieve savings through efforts that focus on costs associated with supplies and other non-labor expenses.

Illustration of human intestinal tract

$5.2M NIH grant bolsters colorectal cancer research

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.

Komen grants bolster breast cancer research

Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research.

obesity or overweight belly

Obesity pathway component identified

Vanderbilt University researchers have discovered a new critical component in the obesity pathway.

Transplant drug added to PREDICT program

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

Flulapalooza vaccination event set for Sept. 25

Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.

1 2